Cases & Deals

Zhongze Therapeutics announces exclusive license of DGX-001 with Digestome Therapeutics for Greater China

Clients Zhongze Therapeutics (Cayman) Holding Limited

Jones Day represented Zhongze Therapeutics (Cayman) Holding, Ltd. in an exclusive license and collaboration agreement with Digestome Therapeutics, Inc. to develop, manufacture, and commercialize Digestome's first-in-class oral therapeutic ALT-100 in the Greater China territory.